Phase II Trial of Subcutaneous Interleukin-2, Subcutaneous Interferon-α, Intravenous Combination Chemotherapy, and Oral Tamoxifen in the Treatment of Metastatic Melanoma: Final Results of Cancer Biotherapy Research Group 94-11
Year: 2000
Type: article
Study design: Clinical Trial
Authors: Robert O. Dillman, Gamini Soori, Michael C. Wiemann, †Richard Schulof, Tracy W. Dobbs, Richard H. Ruben, Carol B. DePriest, Curtis Church
Institution: Hoag Memorial Hospital Presbyterian
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Agencja Badań Medycznych
OpenAlex ID: W2028309712
